AZ's Soriot refuses to rule out mega-merger
This article was originally published in Scrip
Executive Summary
AstraZeneca CEO Pascal Soriot has refused to rule out the possibility of a mega-merger amid a frenzy of speculation over an alleged £60bn approach by Pfizer which came to light earlier this week (scripintelligence.com, 21 April 2014). The company's share price has risen by 10% in the aftermath.